Currently out of the existing stock ratings of David Stanton, 4 are a BUY (100%).

David Stanton

Work Performance Price Targets & Ratings Chart

Analyst David Stanton works at JEFFERIES with a stock forecast success ratio of 66.67% fulfilled within 617 days on average.

David Stanton’s has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MESO, Mesoblast Ltd at 31-Aug-2023.

Wall Street Analyst David Stanton

Analyst best performing recommendations are on MESO (MESOBLAST LTD).
The best stock recommendation documented was for MESO (MESOBLAST LTD) at 1/19/2021. The price target of $2.24 was fulfilled within 527 days with a profit of $7.21 (76.3%) receiving and performance score of 1.45.

Average potential price target upside

MESO Mesoblast Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

0.85

8 months ago

2/3 (66.67%)

$-2.55 (-75.00%)

617

Buy

23

8 months 1 days ago

1/2 (50%)

$15.82 (220.33%)

64

Hold

18

8 months 25 days ago

5/5 (100%)

$1.08 (6.38%)

54

Sell

1.5

$-4.74 (-75.96%)

2

8 months 28 days ago

5/6 (83.33%)

$-1.78 (-54.27%)

305

Hold

2

$-4.24 (-67.95%)

8 months 28 days ago

1/1 (100%)

$-1.28 (-39.02%)

129

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by David Stanton?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?